Stay Informed!

Sign up for one
of our newsletters.

Research Fellowship Recipient Nicholas Mikolajewicz Taking on Glioblastoma

  July 17, 2020

Nicholas Mikolajewicz is a Postdoctoral Researcher at the Terrence Donnelly Centre for Cellular & Biomolecular Research at University of Toronto.

He’s also this year’s William Donald Nash Brain Tumour Research Fellowship Recipient, and Brain Tumour Foundation of Canada is proud to award this fellowship to Nicholas, and commend his commitment to #EndBrainTumours.

Read more about his exciting new project, “Identifying transcriptional drivers of glioblastoma heterogeneity.”


Brief summary of research:

Glioblastoma Multiforme (GBM) remains an incurable brain cancer, largely due to its ability to

transition and co-exist between multiple distinct states within individual patient tumours. Resistant GBM

subpopulations are capable of evading immunotherapy and result in aggressive recurrent tumours with

poor clinical outcomes. This project will use a combination of bioinformatic and genetic tools to identify

gene expression regulators in GBM cells (i.e., transcription factors) that enable the reprogramming of

heterogenous GBM tumours into uniform states that are responsive to immunotherapy. Candidate

transcription factors that control the transition of GBM between different cell states will be identified

using (i) a combination of single-cell transcriptomics and bioinformatics to map GBM-subtype-specific

gene expression patterns to known gene regulators, and (ii) genome-wide CRISPR screens to identify

genes that influence GBM immune resistance. GBM cells will then be genetically-engineered to disrupt

the functions of candidate transcription factors to identify specific genetic perturbation that reprogram

GBM cells into uniform cells states for each GBM subtype. Ultimately, the growth of reprogrammed

GBM tumours in mice receiving tumour-targeting T-cell transfers will be evaluated. This work will

provide novel insights into the drivers of GBM heterogeneity and explore whether reprogramming GBM

tumours can lead to better immunotherapy outcomes.


What receiving this award means to Nicholas:

Being awarded the William Donald Nash Brain Tumour Research Fellowship will allow me to develop an exciting project in glioblastoma that addresses one of the greatest challenges in cancer treatment: How do we treat something that actively evades conventional and emerging treatments? Emerging single-cell genomic technologies make this an exciting time for cancer research, as they provide tools to glimpse into tumor heterogeneity and complexity at an unpreceded single cell-level resolution. Over the term of this fellowship I will develop and apply these technologies to identify novel molecular targets that will reprogram glioblastomas to different states, with the aim being to sensitize these tumors to existing and emerging treatments. As a postdoctoral fellow, this fellowship is an incredible opportunity to develop my own ideas and apply my interdisciplinary training in statistics, cellular biology and single-cell genomics to the complexities presented by glioblastoma. As a medical student, my excitement for this project cannot be overstated as the support of this fellowship sets the stage for me to develop my eventual findings into novel and exciting therapies as a clinician scientist. I am grateful to the Nash Family and the Brain Tumour Foundation of Canada for this generous opportunity, and for supporting my aspirations towards becoming a clinician scientist.